Impel Pharmaceuticals Inc Stock (OTC: IMPL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / - |
Day Range | - - - |
52 Wk Range | 0.021 - 2.870 |
Market Cap | - |
P/E Ratio | - |
Dividend Yield | - |
Exchange | OTC |
RSI | 0 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Impel Pharmaceuticals Inc (OTC: IMPL) through any online brokerage.
There are no as such competitors for Impel Pharmaceuticals Inc.
The latest price target for Impel Pharmaceuticals Inc (OTC: IMPL) was reported by Wedbush on Tuesday, November 15, 2022. The analyst firm set a price target for 5.00 expecting IMPL to fall to within 12 months (a possible NaN% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Impel Pharmaceuticals Inc (OTC: IMPL) is $ last updated .
There are no upcoming dividends for Impel Pharmaceuticals Inc.
Impel Pharmaceuticals Inc’s Q1 earnings are confirmed for Friday, May 24, 2024.
There is no upcoming split for Impel Pharmaceuticals Inc.
Impel Pharmaceuticals Inc is in the Health Care sector and Biotechnology industry. They are listed on the OTC.